Y. Cossart, A. Field, B. Cant, and D. Widdows, PARVOVIRUS-LIKE PARTICLES IN HUMAN SERA, The Lancet, vol.305, issue.7898, pp.72-75, 1975.
DOI : 10.1016/S0140-6736(75)91074-0

J. Pattison, S. Jones, J. Hodgson, L. Davis, J. White et al., PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIA, The Lancet, vol.317, issue.8221, pp.664-669, 1981.
DOI : 10.1016/S0140-6736(81)91579-8

M. Anderson, S. Jones, S. Fisher-hoch, E. Lewis, S. Hall et al., HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?, The Lancet, vol.321, issue.8338, p.1378, 1983.
DOI : 10.1016/S0140-6736(83)92152-9

K. Brown, S. Anderson, and N. Young, Erythrocyte P antigen: cellular receptor for B19 parvovirus, Science, vol.262, issue.5130, pp.114-121, 1993.
DOI : 10.1126/science.8211117

T. Brown, A. Anand, L. Ritchie, J. Clewley, and T. Reid, INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS, The Lancet, vol.324, issue.8410, pp.1033-1037, 1984.
DOI : 10.1016/S0140-6736(84)91126-7

D. Subtil, C. Garabedian, and A. Chauvet, Infection ?? parvovirus B19??et grossesse, La Presse M??dicale, vol.44, issue.6, pp.647-53, 2015.
DOI : 10.1016/j.lpm.2015.04.013

F. Morinet, N. Aladjidi, S. Pillet, and B. Parvovirus, EMC -Pédiatrie -Mal Infect, pp.1-8, 2013.

G. Melica, S. Scerra, J. Lelièvre, F. Morinet, S. Pillet et al., Parvovirus B19, EMC - Maladies infectieuses, vol.8, issue.3, pp.1-6, 2011.
DOI : 10.1016/S1166-8598(11)58122-0

A. Brodin-sartorius, Y. Mekki, B. Bloquel, M. Rabant, and C. Legendre, Infection par le Parvovirus B19??apr??s transplantation r??nale, N??phrologie & Th??rapeutique, vol.8, issue.1, pp.5-12, 2012.
DOI : 10.1016/j.nephro.2011.06.001

L. Bell, S. Naides, P. Stoffman, R. Hodinka, and S. Plotkin, Human Parvo Virus B19 Infection among Hospital Staff Members after Contact with Infected Patients, New England Journal of Medicine, vol.321, issue.8, pp.485-91, 1989.
DOI : 10.1056/NEJM198908243210801

M. Simon, Simian Parvoviruses: Biology and Implications for Research, Comp Med, vol.58, pp.47-50, 2008.

T. Jartti, K. Hedman, L. Jartti, O. Ruuskanen, T. Allander et al., Human bocavirus-the first 5???years, Reviews in Medical Virology, vol.83, issue.1, pp.46-64, 2012.
DOI : 10.1002/rmv.720

P. Matthews, A. Malik, R. Simmons, C. Sharp, P. Simmonds et al., PARV4: An Emerging Tetraparvovirus, PLoS Pathogens, vol.14, issue.5, p.1004036, 2014.
DOI : 10.1371/journal.ppat.1004036.t001

URL : http://doi.org/10.1371/journal.ppat.1004036

A. Servant-delmas, J. Lefrère, F. Morinet, and S. Pillet, Advances in Human B19 Erythrovirus Biology, Journal of Virology, vol.84, issue.19, pp.9658-65, 2010.
DOI : 10.1128/JVI.00684-10

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937825

C. Bönsch, C. Zuercher, P. Lieby, C. Kempf, and R. C. , The Globoside Receptor Triggers Structural Changes in the B19 Virus Capsid That Facilitate Virus Internalization, Journal of Virology, vol.84, issue.22, pp.11737-11783, 2010.
DOI : 10.1128/JVI.01143-10

K. Brown, Haematological consequences of parvovirus B19 infection, Best Practice & Research Clinical Haematology, vol.13, issue.2, pp.245-59, 2000.
DOI : 10.1053/beha.1999.0071

N. Young, K. Brown, and B. Parvovirus, Parvovirus B19, New England Journal of Medicine, vol.350, issue.6, pp.586-97, 2004.
DOI : 10.1056/NEJMra030840

M. Anderson, P. Higgins, L. Davis, J. Willman, S. Jones et al., Experimental Parvoviral Infection in Humans, Journal of Infectious Diseases, vol.152, issue.2, pp.257-65, 1985.
DOI : 10.1093/infdis/152.2.257

V. Mage, D. Lipsker, S. Barbarot, D. Bessis, O. Chosidow et al., Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults, Journal of the American Academy of Dermatology, vol.71, issue.1, pp.62-71, 2014.
DOI : 10.1016/j.jaad.2014.02.044

D. Parra, Y. Mekki, I. Durieu, C. Broussolle, and P. Sève, Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.289-96, 2014.

S. Varache, V. Narbonne, S. Jousse-joulin, X. Guennoc, M. Dougados et al., Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study, Arthritis Care & Research, vol.33, issue.Suppl, pp.1565-70, 2011.
DOI : 10.1002/acr.20576

URL : https://hal.archives-ouvertes.fr/hal-00777346

Y. Crabol, A. Berezné, L. Mouthon, and . Érythroblastopénies, ??rythroblastop??nies, EMC - H??matologie, vol.2, issue.2, pp.1-9, 2007.
DOI : 10.1016/S1155-1984(07)29795-X

R. Whitley, Parvovirus Infection, New England Journal of Medicine, vol.313, issue.2, pp.111-113, 1985.
DOI : 10.1056/NEJM198507113130209

S. Rao, S. Miller, and B. Cohen, Transient Aplastic Crisis in Patients With Sickle Cell Disease, American Journal of Diseases of Children, vol.146, issue.11, pp.1328-1358, 1960.
DOI : 10.1001/archpedi.1992.02160230086025

J. Kelleher, N. Luban, P. Mortimer, and T. Kamimura, Human serum ???parvovirus???: A specific cause of aplastic crisis in children with hereditary spherocytosis, The Journal of Pediatrics, vol.102, issue.5, pp.720-722, 1983.
DOI : 10.1016/S0022-3476(83)80243-1

G. Lugassy, Chronic pure red cell aplasia associated with parvovirus B19 infection in an immunocompetent patient, American Journal of Hematology, vol.78, issue.3, pp.238-247, 2002.
DOI : 10.1002/ajh.10241

P. Saunders, M. Reid, and B. Cohen, HUMAN PARVOVIRUS INDUCED CYTOPENIAS: A REPORT OF FIVE CASES, British Journal of Haematology, vol.302, issue.2, pp.407-417, 1986.
DOI : 10.1111/j.1365-2141.1986.tb05572.x

J. Harger, S. Adler, W. Koch, and G. Harger, Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms, Obstetrics & Gynecology, vol.91, issue.3, pp.413-433, 1998.
DOI : 10.1016/S0029-7844(97)00701-1

C. Brochot, P. Debever, D. Subtil, and F. Puech, Quelles surveillance et thérapeutique appliquer en cas de contage avec le Parvovirus B19 en cours de grossesse ? Gynécologie Obstétrique Fertil, pp.204-215, 2008.
DOI : 10.1016/j.gyobfe.2007.08.028

A. Chauvet, A. Dewilde, D. Thomas, S. Joriot, P. Vaast et al., Ultrasound Diagnosis, Management and Prognosis in a Consecutive Series of 27 Cases of Fetal Hydrops following Maternal Parvovirus B19 Infection, Fetal Diagnosis and Therapy, vol.30, issue.1, pp.41-48, 2011.
DOI : 10.1159/000323821

Z. Ergaz and A. Ornoy, Parvovirus B19 in pregnancy, Reproductive Toxicology, vol.21, issue.4, pp.421-456, 2006.
DOI : 10.1016/j.reprotox.2005.01.006

J. Rodis, A. Borgida, M. Wilson, J. Egan, M. Leo et al., Management of parvovirus infection in pregnancy and outcomes of hydrops: A survey of members of the Society of Perinatal Obstetricians, American Journal of Obstetrics and Gynecology, vol.179, issue.4, pp.985-993, 1998.
DOI : 10.1016/S0002-9378(98)70203-0

H. Nagel, T. De-haan, F. Vandenbussche, D. Oepkes, and F. Walther, Long-Term Outcome After Fetal Transfusion for Hydrops Associated With Parvovirus B19 Infection, Obstetrics & Gynecology, vol.109, issue.1, pp.42-49, 2007.
DOI : 10.1097/01.AOG.0000249611.67873.94

D. Bernstein, E. Sahly, H. Keitel, W. Wolff, M. Simone et al., Safety and immunogenicity of a candidate parvovirus B19 vaccine, Vaccine, vol.29, issue.43, pp.7357-63, 2011.
DOI : 10.1016/j.vaccine.2011.07.080

M. Beersma, E. Claas, T. Sopaheluakan, and A. Kroes, Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples, Journal of Clinical Virology, vol.34, issue.1, pp.71-76, 2005.
DOI : 10.1016/j.jcv.2005.04.005

S. Braham, J. Gandhi, S. Beard, and B. Cohen, Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections, Journal of Clinical Virology, vol.31, issue.1, pp.5-10, 2004.
DOI : 10.1016/j.jcv.2003.10.005

P. Cassinotti, G. Burtonboy, M. Fopp, and G. Siegl, Evidence for persistence of human parvovirus B19 DNA in bone marrow, Journal of Medical Virology, vol.71, issue.3, pp.229-261, 1997.
DOI : 10.1002/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A

T. Takano and K. Yamada, Quantitation of human parvovirus B19 DNA by real-time polymerase chain reaction, Pediatrics International, vol.152, issue.4, pp.459-62, 2007.
DOI : 10.1002/jmv.1890430214

K. Brown, Detection and quantitation of parvovirus B19, Journal of Clinical Virology, vol.31, issue.1, pp.1-4, 2004.
DOI : 10.1016/j.jcv.2004.05.001

Y. Crabol and L. Mouthon, Efficacit?? du traitement par immunoglobulines intraveineuses dans les ??rythroblastop??nies associ??es au parvovirus B19??: une ??tude r??trospective chez dix patients et une revue de 123??cas de la litt??rature, La Revue de M??decine Interne, vol.33, 2012.
DOI : 10.1016/j.revmed.2012.10.156

M. Chen, C. Hung, C. Fang, and S. Hsieh, Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, vol.32, issue.9, pp.1361-1366, 2001.
DOI : 10.1086/319988

E. Renoult, C. Bachelet, M. Krier-coudert, A. Diarrassouba, J. André et al., Recurrent Anemia in Kidney Transplant Recipients With Parvovirus B19 Infection, Transplantation Proceedings, vol.38, issue.7, pp.2321-2324, 2006.
DOI : 10.1016/j.transproceed.2006.06.116

C. Schmidt-lucke, F. Spillmann, T. Bock, U. Kühl, S. Van-linthout et al., Interferon Beta Modulates Endothelial Damage in Patients with Cardiac Persistence of Human Parvovirus B19 Infection, The Journal of Infectious Diseases, vol.201, issue.6, pp.936-981, 2010.
DOI : 10.1086/650700

R. Dennert, S. Velthuis, D. Westermann, D. Donker, S. Schalla et al., Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy, Antiviral Therapy, vol.15, issue.4, pp.681-686, 2010.
DOI : 10.3851/IMP1563

S. Rugolotto, E. Padovani, A. Sanna, G. Chiaffoni, P. Marradi et al., Intrauterine anemia due to parvovirus B19: successful treatment with intravenous immunoglobulins, Haematologica, vol.84, pp.668-677, 1999.

M. Harms, R. Feldmann, and J. Saurat, Papular-purpuric ???gloves and socks??? syndrome, Journal of the American Academy of Dermatology, vol.23, issue.5, pp.850-854, 1990.
DOI : 10.1016/0190-9622(90)70302-X

S. Veraldi, G. Rizzitelli, G. Scarabelli, and C. Gelmetti, Papular-purpuric 'gloves and socks' syndrome, Archives of Dermatology, vol.132, issue.8, pp.975-982, 1996.
DOI : 10.1001/archderm.132.8.975

C. Foti, D. Bonamonte, A. Conserva, M. Grandolfo, C. Casulli et al., Erythema infectiosum following generalized petechial eruption induced by human parvovirus B19, New Microbiol, vol.29, pp.45-53, 2006.

T. Sanz-sánchez, E. Daudén, M. Moreno-de-vega, and A. García-díez, Parvovirus B19 primary infection with vasculitis: DNA identification in cutaneous lesions and sera, Journal of the European Academy of Dermatology and Venereology, vol.167, issue.5, pp.618-638, 2006.
DOI : 10.1016/S0140-6736(95)90850-1

F. Engel, S. Maradeix, L. Braun-parvez, D. Lipsker, and B. Cribier, Vasculite leucocytoclasique compliqu??e d???une atteinte r??nale grave au d??cours d???une primo-infection ?? Parvovirus B19, Annales de Dermatologie et de V??n??r??ologie, vol.134, issue.2, pp.160-163, 2007.
DOI : 10.1016/S0151-9638(07)91610-5

P. Sève, T. Ferry, M. Koenig, P. Cathebras, H. Rousset et al., Lupus-like presentation of parvovirus B19 infection, Seminars in Arthritis and Rheumatism, vol.34, issue.4, pp.642-650, 2005.
DOI : 10.1016/j.semarthrit.2004.07.008

C. Magro, G. Nuovo, C. Ferri, A. Crowson, D. Giuggioli et al., Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma, Journal of Cutaneous Pathology, vol.22, issue.1, pp.43-50, 2004.
DOI : 10.1097/00000372-199706000-00002

D. Tomasini, C. Tomasini, A. Cerri, G. Sangalli, G. Palmedo et al., Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases, Journal of Cutaneous Pathology, vol.133, issue.8, pp.531-539, 2004.
DOI : 10.1046/j.1365-4362.1997.00006.x

F. Drago, G. Ciccarese, F. Broccolo, S. Javor, and A. Parodi, Atypical exanthems associated with Parvovirus B19 (B19V) infection in children and adults, Journal of Medical Virology, vol.2013, issue.11, pp.1981-1985, 2015.
DOI : 10.1002/jmv.24246

T. Tono, Y. Takayama, E. Ogawa, T. Hoshiyama, N. Tono et al., An Adult Case of Acute Pericarditis and Glomerulonephritis Associated with Human Parvovirus B19 Infection, Kansenshogaku Zasshi, vol.87, issue.6, pp.752-757, 2013.
DOI : 10.11150/kansenshogakuzasshi.87.752

C. Bock, K. Klingel, and R. Kandolf, Human Parvovirus B19???Associated Myocarditis, New England Journal of Medicine, vol.362, issue.13, pp.1248-1257, 2010.
DOI : 10.1056/NEJMc0911362

A. Hatakka, J. Klein, R. He, J. Piper, E. Tam et al., Acute Hepatitis as a Manifestation of Parvovirus B19 Infection: Fig. 1., Journal of Clinical Microbiology, vol.49, issue.9, pp.3422-3426, 2011.
DOI : 10.1128/JCM.00575-11

T. Mogensen, J. Jensen, S. Hamilton-dutoit, and C. Larsen, Chronic hepatitis caused by persistent parvovirus B19 infection, BMC Infectious Diseases, vol.93, issue.1, p.246, 2010.
DOI : 10.1111/j.1572-0241.1998.468_1.x

URL : http://doi.org/10.1186/1471-2334-10-246

D. Krygier, U. Steinbrecher, M. Petric, S. Erb, S. Chung et al., Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation, World Journal of Gastroenterology, vol.15, issue.32, pp.4067-4076, 2009.
DOI : 10.3748/wjg.15.4067

M. Douvoyiannis, N. Litman, and D. Goldman, Neurologic Manifestations Associated with Parvovirus B19 Infection, Clinical Infectious Diseases, vol.48, issue.12, pp.1713-1736, 2009.
DOI : 10.1086/599042

URL : http://cid.oxfordjournals.org/cgi/content/short/48/12/1713

F. Barah, S. Whiteside, S. Batista, and J. Morris, Neurological aspects of human parvovirus B19 infection: a systematic review, Reviews in Medical Virology, vol.36, issue.3, pp.154-68, 2014.
DOI : 10.1002/rmv.1782

M. Waldman and J. Kopp, Parvovirus B19 and the Kidney, Clinical Journal of the American Society of Nephrology, vol.2, issue.Supplement 1, pp.47-56, 2007.
DOI : 10.2215/CJN.01060307

M. Buyukkose, E. Kozanoglu, S. Basaran, O. Bayramoglu, and F. Yarkin, Seroprevalence of parvovirus B19 in fibromyalgia syndrome, Clinical Rheumatology, vol.72, issue.6, pp.305-314, 2009.
DOI : 10.1007/s10067-008-1044-4

L. Attard, F. Bonvicini, F. Gelsomino, R. Manfredi, A. Cascavilla et al., Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome, Journal of Clinical Virology, vol.62, pp.54-61, 2015.
DOI : 10.1016/j.jcv.2014.11.021

S. Aslanidis, A. Pyrpasopoulou, K. Kontotasios, S. Doumas, and C. Zamboulis, Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?, European Journal of Internal Medicine, vol.19, issue.5, pp.314-322, 2008.
DOI : 10.1016/j.ejim.2007.09.013

T. Hsu and G. Tsay, Human parvovirus B19 infection in patients with systemic lupus erythematosus, Rheumatology, vol.40, issue.2, pp.152-159, 2001.
DOI : 10.1093/rheumatology/40.2.152

URL : http://ir.lib.csmu.edu.tw:8080/ir/bitstream/310902500/11686/3/index.html

A. Bengtsson, A. Widell, S. Elmstâhl, and G. Sturfelt, No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19, Annals of the Rheumatic Diseases, vol.59, issue.1, pp.64-70, 2000.
DOI : 10.1136/ard.59.1.64

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1752976

V. Landenberg, P. Lehmann, H. Knöll, A. Dorsch, S. Modrow et al., Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection, Arthritis & Rheumatism, vol.46, issue.7, pp.1939-1986, 2003.
DOI : 10.1002/art.11038

Y. Takahashi, C. Murai, S. Shibata, Y. Munakata, T. Ishii et al., Human parvovirus B19 as a causative agent for rheumatoid arthritis, Proceedings of the National Academy of Sciences, vol.95, issue.14, pp.8227-8259, 1998.
DOI : 10.1073/pnas.95.14.8227

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC20958

M. Leruez-ville, A. Laugé, F. Morinet, L. Guillevin, and P. Dény, Polyarteritis riodosa and parvovirus B19, The Lancet, vol.344, issue.8917, pp.263-267, 1994.
DOI : 10.1016/S0140-6736(94)93030-9

P. Chua, V. Nerurkar, Q. Yu, C. Woodward, M. Melish et al., LACK OF ASSOCIATION BETWEEN KAWASAKI SYNDROME AND INFECTION WITH PARVOVIRUS B19, HUMAN HERPESVIRUS 8, TT VIRUS, GB VIRUS C/HEPATITIS G VIRUS OR CHLAMYDIA PNEUMONIAE, The Pediatric Infectious Disease Journal, vol.19, issue.5, pp.477-486, 2000.
DOI : 10.1097/00006454-200005000-00019

S. Gabriel, M. Espy, D. Erdman, J. Bjornsson, T. Smith et al., The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation, Arthritis & Rheumatism, vol.51, issue.6, pp.1255-1263, 1999.
DOI : 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P

L. Harel, R. Straussberg, H. Rudich, A. Cohen, and J. Amir, Raynaud's Phenomenon as a Manifestation of Parvovirus B19 Infection: Case Reports and Review of Parvovirus B19 Rheumatic and Vasculitic Syndromes, Clinical Infectious Diseases, vol.30, issue.3, pp.500-503, 2000.
DOI : 10.1086/313712

D. Dingli, D. Pfizenmaier, E. Arromdee, P. Wennberg, P. Spittell et al., Severe digital arterial occlusive disease and acute parvovirus B19 infection, The Lancet, vol.356, issue.9226, pp.312-316, 2000.
DOI : 10.1016/S0140-6736(00)02512-5

C. Page, G. Duverlie, H. Sevestre, and R. Desailloud, Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses, Journal of Medical Virology, vol.350, issue.1, pp.162-171, 2015.
DOI : 10.1002/jmv.23963

J. Kerr, The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease, Journal of Clinical Pathology, vol.64, issue.(Suppl D), pp.279-91, 2016.
DOI : 10.1136/jclinpath-2015-203455

G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese et al., Immune response to B19 parvovirus and an antibody defect in persistent viral infection., Journal of Clinical Investigation, vol.84, issue.4, pp.1114-1137, 1989.
DOI : 10.1172/JCI114274

J. Clarke and J. Lee, Primary human parvovirus B19 infection in an HIV infected patient on highly active antiretroviral therapy, Sexually Transmitted Infections, vol.79, issue.4, pp.336-336, 2003.
DOI : 10.1136/sti.79.4.336

N. Frickhofen, J. Abkowitz, M. Safford, J. Berry, J. Antunez-de-mayolo et al., Persistent B19 Parvovirus Infection in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1): A Treatable Cause of Anemia in AIDS, Annals of Internal Medicine, vol.113, issue.12, pp.926-959, 1990.
DOI : 10.7326/0003-4819-113-12-926

S. Parekh, A. Perez, X. Yang, and H. Billett, Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia, American Journal of Hematology, vol.343, issue.1, pp.54-61, 2005.
DOI : 10.1002/ajh.20313

R. Sterpu, H. Ichou, I. Mahé, and E. Mortier, R??activation d???une infection ?? parvovirus??B19??chez une patiente infect??e par le VIH, La Revue de M??decine Interne, vol.35, issue.6, pp.396-404, 2014.
DOI : 10.1016/j.revmed.2013.05.009

J. Kerr, A review of blood diseases and cytopenias associated with human parvovirus B19 infection, Reviews in Medical Virology, vol.36, issue.7, pp.224-264, 2015.
DOI : 10.1002/rmv.1839

P. Cohen, B. Guillet, and G. Tchernia, parvovirus B19 en hematologie, Hematologie, vol.9, pp.389-401, 2003.

A. Wolfromm, C. Rodriguez, M. Michel, A. Habibi, V. Audard et al., Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice, British Journal of Haematology, vol.350, issue.2, pp.192-201, 2015.
DOI : 10.1111/bjh.13421

K. Matsubara, Y. Uchida, T. Wada, A. Iwata, K. Yura et al., Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Child With Precursor B-cell Acute Lymphoblastic Leukemia Under Maintenance Chemotherapy, Journal of Pediatric Hematology/Oncology, vol.33, issue.7, pp.565-574, 2011.
DOI : 10.1097/MPH.0b013e3182099a54

J. Kerr and D. Mattey, The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia, Reviews in Medical Virology, vol.30, issue.1, pp.133-55, 2015.
DOI : 10.1002/rmv.1830

A. Srivastava, E. Bruno, R. Briddell, R. Cooper, C. Srivastava et al., Parvovirus B19- induced perturbation of human megakaryocytopoiesis in vitro, Blood, vol.76, pp.1997-2004, 1990.

M. Bagot and J. Revuz, Papular-purpuric ???gloves and socks??? syndrome: Primary infection with parvovirus B19?, Journal of the American Academy of Dermatology, vol.25, issue.2, pp.341-343, 1991.
DOI : 10.1016/S0190-9622(08)80483-5

C. Santonja, G. Nieto-gonzález, Á. Santos-briz, G. Zufiaurre, M. De-las et al., Immunohistochemical Detection of Parvovirus B19 in ???Gloves and Socks??? Papular Purpuric Syndrome: Direct Evidence for Viral Endothelial Involvement. Report of Three Cases and Review of the Literature, The American Journal of Dermatopathology, vol.33, issue.8, pp.790-795, 2011.
DOI : 10.1097/DAD.0b013e318221bc41

S. Aractingi, D. Bakhos, B. Flageul, O. Vérola, M. Brunet et al., Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome, British Journal of Dermatology, vol.126, issue.4, pp.599-602, 1996.
DOI : 10.1136/jcp.36.11.1256

G. Martínez, . Mj, and N. A. Elgueta, A family outbreak of parvovirus B19 atypical exanthemas: report of two cases]. Rev Médica Chile, pp.620-623, 2008.

J. Lefrère, A. Couroucé, J. Soulier, M. Cordier, G. Girault et al., Henoch-Schönlein purpura and human parvovirus infection, Pediatrics, vol.78, pp.183-187, 1986.

T. Finkel, D. Leung, R. Harbeck, E. Gelfand, T. Török et al., Issue 8908Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? The Lancet, pp.1255-1263, 1994.

S. Nikkari, J. Mertsola, H. Korvenranta, F. Vainionpää, and P. Toivanen, Wegener's granulomatosis and parvovirus, Arthritis & Rheumatism, vol.343, issue.11, pp.1707-1715, 1994.
DOI : 10.1002/art.1780371122

A. Crowson, C. Magro, and M. Dawood, A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes, Journal of Cutaneous Pathology, vol.27, issue.10, pp.505-520, 2000.
DOI : 10.1034/j.1600-0560.2000.027010505.x

I. Naceur, I. Kechaou, E. Cherif, Z. Kaouach, I. Boukhris et al., Vascularite cryoglobulin??mique et primo-infection au parvovirus B19??: ?? propos de deux observations, La Revue de M??decine Interne, vol.35, pp.125-131, 2014.
DOI : 10.1016/j.revmed.2014.10.210

P. Ferguson, F. Saulsbury, S. Dowell, T. Török, D. Erdman et al., Prevalence of human parvovirus B19 infection in children with Henoch-Sch??nlein purpura, Arthritis & Rheumatism, vol.262, issue.5, pp.880-881, 1996.
DOI : 10.1002/art.1780390523

C. Salvarani, E. Farnetti, B. Casali, D. Nicoli, L. Wenlan et al., Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: A case-control study, Arthritis & Rheumatism, vol.349, issue.11, pp.3099-101, 2002.
DOI : 10.1002/art.10580

A. Morey, J. Keeling, H. Porter, and K. Fleming, Clinical and histopathological features of parvovirus B19 infection in the human fetus, BJOG: An International Journal of Obstetrics and Gynaecology, vol.96, issue.7, pp.566-74, 1992.
DOI : 10.1016/S0140-6736(87)90442-9

A. Dijkmans, E. De-jong, B. Dijkmans, E. Lopriore, A. Vossen et al., Parvovirus B19 in pregnancy, Current Opinion in Obstetrics and Gynecology, vol.24, issue.2, pp.95-101, 2012.
DOI : 10.1097/GCO.0b013e3283505a9d

E. Gratacós, P. Torres, J. Vidal, E. Antolín, J. Costa et al., The Incidence of Human Parvovirus B19 Infection during Pregnancy and Its Impact on Perinatal Outcome, Journal of Infectious Diseases, vol.171, issue.5, pp.1360-1363, 1995.
DOI : 10.1093/infdis/171.5.1360

D. Dieck, R. Schild, M. Hansmann, and A. Eis-hübinger, Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum, Prenatal Diagnosis, vol.34, issue.12, pp.1119-1142, 1999.
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1119::AID-PD716>3.0.CO;2-X

M. Enders, A. Weidner, and G. Enders, Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany, Epidemiology and Infection, vol.135, issue.04, pp.563-572, 2007.
DOI : 10.1017/S095026880600731X

T. De-haan, M. Beersma, D. Oepkes, E. De-jong, A. Kroes et al., Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters, Prenatal Diagnosis, vol.34, issue.1, pp.46-50, 2007.
DOI : 10.1002/pd.1619

L. Mouthon and L. Guillevin, Immunoglobulines intraveineuses : quelles indications thérapeutiques anti-infectieuses ? EMC. [Internet], 2008.
DOI : 10.1016/s0755-4982(06)74668-1

C. Chen, C. Chen, W. Wang, J. Ma, H. Shu et al., Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report, Journal of Medical Case Reports, vol.22, issue.1, p.58, 2015.
DOI : 10.1016/j.blre.2007.08.002

M. Mant, Chronic idiopathic pure red cell aplasia: successful treatment during pregnancy and durable response to intravenous immunoglobulin, Journal of Internal Medicine, vol.65, issue.Suppl. 2, pp.593-598, 1994.
DOI : 10.1111/j.1365-2796.1994.tb00851.x

A. Selbing, A. Josefsson, L. Dahle, and R. Lindgren, Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin, The Lancet, vol.345, issue.8950, pp.660-661, 1995.
DOI : 10.1016/S0140-6736(95)90569-3

P. Rouger, P. Gane, and C. Salmon, Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies, Revue Francaise de Transfusion et Immuno-h??matologie, vol.30, issue.5, pp.699-708, 1987.
DOI : 10.1016/S0338-4535(87)80138-1

Y. Yoto, T. Kudoh, N. Suzuki, S. Katoh, Y. Matsunaga et al., Thrombocytopenia induced by human parvovirus B19 infections, European Journal of Haematology, vol.9, issue.5, pp.255-262, 1993.
DOI : 10.1111/j.1600-0609.1993.tb00158.x

G. Barlow and M. Mckendrick, Parvovirus B19 causing leucopenia and neutropenia in a healthy adult, Journal of Infection, vol.40, issue.2, pp.192-197, 2000.
DOI : 10.1016/S0163-4453(00)80018-3

A. Lindblom, M. Heyman, I. Gustafsson, O. Norbeck, T. Kaldensjö et al., Parvovirus B19 Infection in Children with Acute Lymphoblastic Leukemia is Associated with Cytopenia Resulting in Prolonged Interruptions of Chemotherapy, Clinical Infectious Diseases, vol.46, issue.4, pp.528-564, 2008.
DOI : 10.1086/526522

C. Urban, H. Lackner, E. Müller, M. Benesch, V. Strenger et al., Stem Cell Transplantation in 6 Children with Parvovirus B19- Induced Severe Aplastic Anaemia or Myelodysplastic Syndrome, Klinische P??diatrie, vol.223, issue.06, pp.332-336, 2011.
DOI : 10.1055/s-0031-1287839

R. Rajput, A. Sehgal, D. Jain, R. Sen, and A. Gupta, Acute Parvovirus B19 Infection Leading to Severe Aplastic Anemia in a Previously Healthy Adult Female, Indian Journal of Hematology and Blood Transfusion, vol.32, issue.2, pp.123-129, 2012.
DOI : 10.1007/s12288-011-0112-0

M. Osaki, K. Matsubara, T. Iwasaki, T. Kurata, H. Nigami et al., Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease, Annals of Hematology, vol.78, issue.2, pp.83-89, 1999.
DOI : 10.1007/s002770050477

J. Hankins, R. Penkert, P. Lavoie, L. Tang, Y. Sun et al., Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era, Experimental Biology and Medicine, vol.169, issue.4, pp.749-54, 2016.
DOI : 10.1182/blood-2012-03-419879

D. Pardi, Y. Romero, L. Mertz, and D. Douglas, HEPATITIS-ASSOCIATED APLASTIC ANEMIA AND ACUTE PARVOVIRUS B19 INFECTION: A REPORT OF TWO CASES AND A REVIEW OF THE LITERATURE, American Journal of Gastroenterology, vol.34, issue.3, pp.468-70, 1998.
DOI : 10.1111/j.1572-0241.1998.468_1.x